Rechargeable Metal–Air Proton‐Exchange Membrane Batteries for Renewable Energy Storage

Rechargeable proton‐exchange membrane batteries that employ organic chemical hydrides as hydrogen‐storage media have the potential to serve as next‐generation power sources; however, significant challenges remain regarding the improvement of the reversible hydrogen‐storage capacity. Here, we address this challenge through the use of metal‐ion redox couples as energy carriers for battery operation. Carbon, with a suitable degree of crystallinity and surface oxygenation, was used as an effective anode material for the metal redox reactions. A Sn0.9In0.1P2O7‐based electrolyte membrane allowed no crossover of vanadium ions through the membrane. The V4+/V3+, V3+/V2+, and Sn4+/Sn2+ redox reactions took place at a more positive potential than that for hydrogen reduction, so that undesired hydrogen production could be avoided. The resulting electrical capacity reached 306 and 258 mAh g−1 for VOSO4 and SnSO4, respectively, and remained at 76 and 91 % of their respective initial values after 50 cycles.Positive exchange: A proton‐exchange membrane fuel cell is integrated with active anode materials including vanadium and tin ions, for which redox reactions occur at more positive potentials than for hydrogen reduction. These redox couples are demonstrated to function as promising energy‐storage media with excellent reversibility and good cyclability.Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/137429/1/celc201500473-sup-0001-misc_information.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/137429/2/celc201500473.pd

Mitigation of hydrogen embrittlement by carbon monoxide impurity in gaseous H2

Please click Additional Files below to see the full abstrac

Mechanistic model for hydrogen accelerated fatigue crack growth in a low carbon steel

Please click Additional Files below to see the full abstrac

DOCK2 is involved in the host genetics and biology of severe COVID-19

「コロナ制圧タスクフォース」COVID-19疾患感受性遺伝子DOCK2の重症化機序を解明 --アジア最大のバイオレポジトリーでCOVID-19の治療標的を発見--. 京都大学プレスリリース. 2022-08-10.Identifying the host genetic factors underlying severe COVID-19 is an emerging challenge. Here we conducted a genome-wide association study (GWAS) involving 2, 393 cases of COVID-19 in a cohort of Japanese individuals collected during the initial waves of the pandemic, with 3, 289 unaffected controls. We identified a variant on chromosome 5 at 5q35 (rs60200309-A), close to the dedicator of cytokinesis 2 gene (DOCK2), which was associated with severe COVID-19 in patients less than 65 years of age. This risk allele was prevalent in East Asian individuals but rare in Europeans, highlighting the value of genome-wide association studies in non-European populations. RNA-sequencing analysis of 473 bulk peripheral blood samples identified decreased expression of DOCK2 associated with the risk allele in these younger patients. DOCK2 expression was suppressed in patients with severe cases of COVID-19. Single-cell RNA-sequencing analysis (n = 61 individuals) identified cell-type-specific downregulation of DOCK2 and a COVID-19-specific decreasing effect of the risk allele on DOCK2 expression in non-classical monocytes. Immunohistochemistry of lung specimens from patients with severe COVID-19 pneumonia showed suppressed DOCK2 expression. Moreover, inhibition of DOCK2 function with CPYPP increased the severity of pneumonia in a Syrian hamster model of SARS-CoV-2 infection, characterized by weight loss, lung oedema, enhanced viral loads, impaired macrophage recruitment and dysregulated type I interferon responses. We conclude that DOCK2 has an important role in the host immune response to SARS-CoV-2 infection and the development of severe COVID-19, and could be further explored as a potential biomarker and/or therapeutic target